Important approved medicines from CMOs/founders of Alnylam and Biogen : Garg Sharp Sandrock Singhal. Plus the Celts beat the Cavs ??
Longwood Fund
风险投资与私募股权管理人
Boston，MA 3,064 位关注者
Longwood creates and invests in science-based companies that develop novel solutions for important medical problems
关于我们
Longwood creates and invests in science-based companies that develop novel solutions for important medical problems.
- 网站
-
https://www.longwoodfund.com
Longwood Fund的外部链接
- 所属行业
- 风险投资与私募股权管理人
- 规模
- 2-10 人
- 总部
- Boston，MA
- 类型
- 合营企业
- 创立
- 2010
- 领域
- Healthcare and Biotech和entrepreneurialism
地点
-
主要
获取路线
800 Boylston Street
US，MA，Boston，02199
Longwood Fund员工
动态
-
Miami CEO convenes senior industry executives for an annual leadership summit on Key Biscayne with valuable discussion and networking opportunities, including an evening out for sunset cocktails and dinner at the Key Biscayne Yacht Club. To request an invitation, email?[email protected].
此处无法显示此内容
在领英 APP 中访问此内容等
-
Miami CEO convenes a limited number of biopharma CEOs, investors, and researchers for unique networking opportunities and off-the-record discussion with leaders in the industry at The @RitzCarlton Key Biscayne. https://conta.cc/3YXkSeX
-
-
Just ahead of #JPM2025, join leaders in the industry for a 2-day networking and discussion forum?at Four Seasons Hotel San Francisco, the Saturday and Sunday immediately prior to #JPMweek. See details:?https://conta.cc/40A8jbP
-
-
We were honored to feature Brad Margus in a non-profit spotlight at Boston CEO last week as he shared the important work he and the @atchildrensproject are doing to advance research in #ataxiatelangiectasia and #genetherapy. See his call for researchers below and spread the word about this important initiative. https://atcp.org/
Co-founder & Board Chair at Cerevance | Founder & Volunteer Chair at A-T Children's Project
I still need your help persuading gene therapy experts to spend a few hours with us! Just twelve days from now, scientists, clinicians, and drug developers from around the world will gather in Boston to explore gene therapy approaches for treating my sons' devastating disease, ataxia telangiectasia (A-T). It robs kids of muscle control, balance, speech, swallowing and eye-tracking, while also causing immune deficiencies, lung problems, and a high cancer risk. After reviewing A-T's symptoms, cellular phenotype, and the mutated ATM gene, we'll review efforts now underway to develop and test antisense oligonucleotide (ASO) therapies in A-T kids who have specific mutations that can be addressed with this approach. BUT WE URGENTLY NEED EXPERTS IN OTHER APPROACHES BEYOND ASOs! We’re seeking insights into gene delivery options—AAV, lentivirus, non-viral, and dual-vector strategies (the ATM gene is large)—along with advanced gene editing techniques, including CRISPR, base, and prime editing. I can promise you that we’re prepared to act immediately on what we learn. Tools are in place to drive research forward: cell lines made from A-T kids, post-mortem brain tissue samples, in vitro assays, animal models, data platforms, neuroimaging, biomarkers, wearable devices, clinical scales, and natural history studies. This meeting will also guide our funding priorities. Please help us by sharing this post with your network and encouraging any friends involved in gene therapy to join us in Boston Nov 19-20. They should reach out to Jennifer Thornton at?[email protected]?to learn more. Thanks for helping us move closer to treatments for kids with A-T!
-
-
Congratulations to TScan Therapeutics for its continued progress in the clinic. Read the release here: https://lnkd.in/e4Dc3Jx5
Today we announced that preliminary results from the ALLOHA? Phase 1 trial of TSC-100 and TSC-101 in patients with #AML, #ALL, and #MDS will be featured in an oral presentation at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition being held December 7 – 10 in San Diego, CA. Join our virtual KOL event on Tuesday, December 10 at 8:00 a.m. ET where we will discuss the data presented at #ASH24. Learn more: https://bit.ly/3UH9gez #CellTherapy
-
-
Thank you to the extraordinary thought leaders across the healthcare spectrum who have joined us over the past two days at #BostonCEO. We're inspired?you for sharing insights across #pharma #biotech #healthcare #government #investment #patient communities. Join us next time! https://lnkd.in/eHf-4X5f
-
-
Terrific discussion on #Biomanufacturing: planning for future success Al Gianchetti XyloCor Therapeutics, Inc., Marinna Madrid, PhD Cellino, Hari Pujar Tessera Therapeutics Flagship Pioneering Avi Nandi SK pharmteco & Andrew Obenshain bluebird bio
-
-
A wonderful discussion with R&D heads of Novo Nordisk and Novartis Fiona H. Marshall and Kailash Swarna Accenture & Christoph Westphal Longwood Fund !
-
-
Wonderful discussion on navigating the #science #innovation and challenges of identifying #nextgeneration therapeutics. Thank you ROME Therapeutics, Candel Therapeutics, Akamis Bio, Delix Therapeutics led by SmartLabs.
-